Bioethics News

Outsourcing of Drug Trials Is Faulted

Now, an article about the globalization of clinical trials, published Thursday in The New England Journal of Medicine raises questions about the ethics and the science of increasingly conducting studies outside the United States — when the studies are meant to gather evidence for new drugs to gain approval in this country. The article, by several Duke University researchers, suggests an ethical quagmire when drugs intended for wealthy nations are tested on people in developing countries.

more

Posted in Biomedical research ethics | Comments Off on Outsourcing of Drug Trials Is Faulted

Drug company ‘hid’ suicide link

Secret e-mails reveal that the UK’s biggest drug company distorted trial results of an anti-depressant, covering up a link with suicide in teenagers. Panorama reveals that GlaxoSmithKline (GSK) attempted to show that Seroxat worked for depressed children despite failed clinical trials.

more

Posted in Biomedical research ethics | Comments Off on Drug company ‘hid’ suicide link

Animal studies ‘of limited use’

The British Medical Journal research looked at studies in six areas and found animal studies agreed with human trials in just three. The high-profile London drug trial which left six men ill was carried out after animal studies showed the drug TGN1412 was effective.

more

Posted in Biomedical research ethics | Comments Off on Animal studies ‘of limited use’

Industry ‘paid top cancer expert’

The scientist who first linked smoking to lung cancer was paid by a chemicals firm while investigating cancer risks in the industry, it has emerged.

more

Posted in Biomedical research ethics | Comments Off on Industry ‘paid top cancer expert’

UK drug trial disaster: the official report

The final report into a catastrophic drug safety trial that left six men fighting for their lives in the UK in March 2006 has severely criticised Parexel, the firm that carried out the trial.

more

Posted in Biomedical research ethics | Comments Off on UK drug trial disaster: the official report

Risky business: Human testing for a profit

Last week, six very healthy men suddenly wound up in a London hospital in critical condition. Earlier this month, 11 otherwise well people tested positive for tuberculosis, according to Montreal`s health department.

more

Posted in Biomedical research ethics | Comments Off on Risky business: Human testing for a profit

Hwang Woo-Suk Fired From U. for Faked Embryonic Stem Cell Research

Seoul National University officially fired disgraced scientist Hwang Woo-suk on Monday from his position as a professor of veterinary medicine because of his role in faking embryonic stem cell research. The decision was a formality because Hwang resigned from in December after allegations of fraud began to surface.

more

Posted in Biomedical research ethics | Comments Off on Hwang Woo-Suk Fired From U. for Faked Embryonic Stem Cell Research

Blastomere Blasphemy: Advanced Cell Technology, the Media and the Lost Opportunity in Stem Cell Research

Millions of people who have already been born suffer from illnesses that can potentially be treated with stem or progenitor-cell based therapies. The true crime is the stifling of hES cell research.

more

Posted in Stem cell research | Comments Off on Blastomere Blasphemy: Advanced Cell Technology, the Media and the Lost Opportunity in Stem Cell Research

Stem cell treatment for ill girl

A five-year-old girl from Sussex has started receiving stem cell therapy in a remote hospital in China in an attempt to halt a degenerative disease.

more

Posted in Stem cell research | Comments Off on Stem cell treatment for ill girl

A written consent five centuries ago

The term informed consent does not have long historical roots. Until recent centuries, healthcare professionals were not held responsible for providing information to patients.

more

Posted in Doctor-patient relationship | Comments Off on A written consent five centuries ago